Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
Tel: |
15076683720 |
Email: |
klq@cw-bio.com |
Products Intro: |
Product Name:WAY-340935 CAS:737818-56-3 Purity:≥98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
|
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Basic information |
Product Name: | Quinazoline, 4-[(4-bromophenyl)methoxy]- | Synonyms: | Quinazoline, 4-[(4-bromophenyl)methoxy]-;WAY-340935;4-((4-Bromobenzyl)oxy)quinazoline;WAY-340935(VEGFR2-IN-2);Inhibitor,WAY340935,Vascular endothelial growth factor receptor,WAY 340935,inhibit,VEGFR,Anticancer;VEGFR2-IN-2 | CAS: | 737818-56-3 | MF: | C15H11BrN2O | MW: | 315.16 | EINECS: | | Product Categories: | | Mol File: | 737818-56-3.mol | |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Chemical Properties |
Boiling point | 455.0±25.0 °C(Predicted) | density | 1.494±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 63 mg/mL (199.90 mM);Ethanol: 3 mg/mL (9.52 mM) | pka | 2.66±0.30(Predicted) | Water Solubility | Water: Insoluble |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Usage And Synthesis |
Biological Activity | WAY-340935 (VEGFR2-IN-2) can inhibit the function of VEGFR2 and the anti-proliferative activity against the H460 cell line is produced partly by interaction of VEGFR protein. | References | [1] Sun J, et al. Org Biomol Chem. 2013 Nov 28;11(44):7676-86. |
| Quinazoline, 4-[(4-bromophenyl)methoxy]- Preparation Products And Raw materials |
|